Related Experiment Videos
Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors
M Aragona1, C A Buda, S Panetta
1Unita Operativa di Oncologia Medica, Universita di Messina, 98121 Messina, Italy. aragona@sirio-oncology.it
Oncology Reports
|August 19, 2000
Summary
Telomere length maintenance is crucial in cancer. This study found that reduced expression of telomeric-repeat binding factor-1 (TRF1) in gastrointestinal tumor cells may promote cell immortalization, a potential early step in carcinogenesis.
Area of Science:
- Oncology
- Cell Biology
- Gastroenterology
Background:
- Telomere length maintenance is implicated in cancer development.
- Telomeric-repeat binding factor-1 (TRF1) physiologically modulates telomere maintenance.
- TRF1 deletion allows telomere elongation.
Purpose of the Study:
- To investigate TRF1 expression in gastrointestinal neoplastic and non-neoplastic tissues.
- To explore the role of TRF1 down-regulation in gastrointestinal carcinogenesis.
Main Methods:
- Immunohistochemistry was used to assess TRF1 expression in 19 gastrointestinal tumors and 12 non-neoplastic tissues.
- Anti-TRF1 polyclonal antibody was utilized.
- Ki67 and p53 expression were also evaluated.
Main Results:
- TRF1 was expressed in differentiated, non-proliferating epithelial cells but not in most tumor cells (p<0.0001).
- p53 was expressed in 26% of tumor cases.
- Epithelial cells in inflammatory tissues showed lower TRF1 expression than normal tissues (p=0.008).
Conclusions:
- Down-regulation of TRF1 expression in tumor cells may contribute to cell immortalization during early gastrointestinal carcinogenesis, potentially preceding p53 alterations.
- These findings suggest TRF1 may serve as a prognostic marker in gastrointestinal tumors.